Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
17.82
+0.53 (3.07%)
Jul 20, 2026, 4:00 PM EDT - Market closed
Beta Bionics Revenue
Beta Bionics had revenue of $27.63M in the quarter ending March 31, 2026, with 56.62% growth. This brings the company's revenue in the last twelve months to $110.24M, up 57.87% year-over-year. In the year 2025, Beta Bionics had annual revenue of $100.25M with 53.94% growth.
Revenue (ttm)
$110.24M
Revenue Growth
+57.87%
P/S Ratio
7.20
Revenue / Employee
$260,610
Employees
423
Market Cap
794.09M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 100.25M | 35.13M | 53.94% |
| Dec 31, 2024 | 65.12M | 53.13M | 442.93% |
| Dec 31, 2023 | 12.00M | 11.82M | 6,601.12% |
| Dec 31, 2022 | 179.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBBNX News
- 5 days ago - Beta Bionics price target raised to $19 from $17 at Goldman Sachs - TheFly
- 7 days ago - Beta Bionics price target raised to $22 from $18 at Truist - TheFly
- 19 days ago - Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026 - GlobeNewsWire
- 5 weeks ago - Johnson Fistel Continues Investigation of Beta Bionics, Inc. (BBNX) - Business Wire
- 5 weeks ago - Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth - PRNewsWire
- 6 weeks ago - Robbins LLP Reminds BBNX Stockholders of its Investigation into Beta Bionics, Inc.; Contact the Firm for Information - GlobeNewsWire
- 6 weeks ago - Beta Bionics, Inc. (BBNX) Investigation: Johnson Fistel Investigates Investor Losses Following Slower New Patient Start Growth - GlobeNewsWire
- 6 weeks ago - Beta Bionics management to meet with Piper Sandler - TheFly